alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Diabetes, Endocrinology and Metabolic Diseases B Study Section Diabetes, Endocrinology and Metabolic Diseases B Study Section (DDK-B).                    

*Date:*                         March 6-8, 2024.                    

*Time:*                         10:00 a.m. to 3:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, NIDDK Democracy II, Suite 7000A 6707 Democracy Boulevard Bethesda, MD 20892 (Virtual Meeting)                    

*Contact Person:*                         Charlene J. Repique, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7347, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7791,                         *charlene.repique@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: January 25, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-01822 Filed 1-29-24; 8:45 am]

BILLING CODE 4140-01-P
acls_Ex10_13


		
			Exhibit 10.13
		

		
			Axcelis Technologies, Inc.
		

		
			Non‐Employee Director Cash Compensation at March 14, 2017
		

		
			This Exhibit discloses the current understandings with respect to cash compensation between Axcelis Technologies, Inc. (the “Company”) and each of its non‐employee directors. Axcelis provides both cash retainers to its non‐employee directors, as follows:
		

			
					
						 

					
					
						 

				
	
					
						Annual Cash Retainers, paid quarterly in advance

					
						 

				
	
					
						Board Member Retainer

					
					
						$50,000

				
	
					
						Independent Chairman Premium

					
					
						$20,000

				
	
					
						Committee Chair Retainers

					
					
						 

				
	
					
						Audit Committee Chairman

					
					
						$15,000

				
	
					
						Compensation Committee Chairman

					
					
						$10,000

				
	
					
						Nominating and Governance Committee Chairman

					
					
						$7,500

				
	
					
						Technology Committee Chairman

					
					
						$7,500

				
	
					
						Committee Member (not Chairman) Retainers

					
					
						 

				
	
					
						Audit Committee Member

					
					
						$10,000

				
	
					
						Compensation Committee Member

					
					
						$7,500

				
	
					
						Nominating and Governance Committee Member

					
					
						$5,000

				
	
					
						Technology Committee Member

					
					
						$5,000

				



		
			 
		

		
			 
		

		
			
		

		
			Non‐employee directors also receive reimbursement of out‐of‐pocket expenses incurred in attending Board and committee meetings.  Non‐employee directors do not receive any Company‐paid perquisites.
		

		
			 
		

		
			The Board of Directors may, from time to time, form committees in addition to the Audit, Compensation, Nominating and Governance and Technology Committees and set compensation for service on such additional committees.
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

NATIONAL VEHICLE AND FUEL EMISSIONS LABORATORY

2000 TRAVERWOOD DRIVE

ANN ARBOR, MI 48105-2498

 OFFICE OF

AIR AND RADIATION

December 12, 2013

MEMORANDUM

SUBJECT: Meeting between API and EPA on Tier 3 Gasoline Sulfur

FROM: Christine Brunner, OAR/OTAQ/ASD

TO: EPA Docket # EPA-HQ-OAR-2011-0135

This memo documents a meeting held on December 6, 2013 between representatives of 

the American Petroleum Institute (API) and EPA to discuss EPA’s proposed Tier 3 gasoline 

sulfur provisions. The list of meeting attendees from both API and EPA, as well as a handout 

from API, are attached.
U.S. Department 

of Transportation 

Federal Aviation 

Administration 

Mr. David M. McDonald 

VP, General Counsel 

Aeronautical Engineers, Inc. 

7765 Northwest 54th Street 

Miami, Florida 33166 

Dear Mr. McDonald: 

Transport Airplane Directorate 

1601 Lind Avenue, S.W. 

Renton, Washington 98057-3356 

This is in regard to your petition letter dated August 22, 2014, in which you requested 

exemption from the requirements of§§ 25.785G), 25.812(e), 25.855(a), 25.857(e), 

25.1447(c)(1), and 25.1449 ofTitle 14, Code ofFederal Regulations. The exemption, if 

granted, would allow the carriage of up to three non-crewmembers (commonly referred to as 

supernumeraries) in an area aft of the flight deck and forward of the 9G bulkhead on 

Bombardier CRJ200 (CL-600-2819) freighter conversions to attend to special cargo. Your 

request was placed in the Department of Transportation's Federal Docket Management 

System (Regulations.gov) and assigned Docket No. FAA-2014-0636. 

In our letter dated September 8, 2014, we informed you that we were in the process of 

reviewing your request and that we would contact you if we needed additional information. 

This is to notify you that in order to make a decision on your request, we do require 

additional information. Therefore, please provide detailed information to help us understand 

the following issues: 

1. Aeronautical Engineers, Inc. (AEI) is requesting that up to three supernumeraries 

(meeting the requirements of§ 121.583) be allowed to occupy an area aft of the 

flight deck and forward of the 9G bulkhead ("supernumerary area"). However, in 

the CL-600-2819, there is only room for two seats in the supernumerary area. 

Please clarify whether AEI intends to include up to three supernumeraries in the 

supernumerary area or if one of the supernumeraries will be seated in the flight deck. 

For your information, anyone seated in the flight deck area does not require an 

exemption. 

2. The supporting information in your petition describes how some operators of AEI 

freighters need to be able to carry supernumeraries to assist with special cargo. Does 

AEI intend to allow access to the Class E cargo compartment during flight? 
3. The "Related regulations" section (page 2) of your petition lists §121.285 (carriage 

of cargo in passenger compartments). Please explain your intent for including this 

reference in your request. 

Please provide the requested additional information within 30 days of the date ofthis letter 

by submitting it to the established docket (Docket No. FAA-2014-0636). If the information 

is not submitted within that timeframe, we will cease work on the project with no further 

correspondence to you. Please note that work will only resume when we receive your 

additional information, addressed to the established docket on Regulations.gov. 

Should you have any questions or concerns regarding your petition or the petition process, 

please contact Mr. Alan Sinclair at (425) 227-2195 or Alan.Sinclair@faa.gov. 

Sincerely, 

Suzanne asterson 

Manager, Airframe & Cabin Safety 

Transport Standards Staff 

2
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the  Quarterly  Report of  Entertainment  Is Us, Inc.  (the
"Company") on Form 10-QSB for the quarter ended  December 31, 2005 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Noriyuki Kanayama, Chief Executive Officer of the Company,  certify, pursuant to
18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities and Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and result of operations of the Company.

A signed  original of this  written  statement  required by Section 906 has been
provided to Entertainment Is Us, Inc, Inc. and will be retained by Entertainment
Is Us, Inc, Inc. and furnished to the Securities and Exchange  Commission or its
staff upon request.

February 21, 2006





                            /s/ Noriyuki Kanayama
                            ----------------------
                            Noriyuki Kanayama
                            Chief Executive Officer
1

Edwards, Brenda

From: Somasundaram, Sriram [sriram.somasundaram@pnl.gov]

Sent: Thursday, February 28, 2008 4:59 PM

To: Edwards, Brenda

Cc: Aris Marantan; Matthew Millard; Parker, Graham B; Llenza, Charles

Subject: Refrigerated Beverage Vending Machines - Docket Number EE-2006-STD-0125 - Docket 

directory and comment # 18

Brenda,

Thank you for logging this e-mail into the docket. I have a request for you to put the 

following record of a phone conversation as another record (Comment #18) into the BVM 

docket.

_______________________

Sriram Somasundaram called Bob McGarrah of USA Technologies in May 2007 to find out if Bob

had any data or information regarding the split of the beverage vending machines rated for

indoor/outdoor use only that were installed indoors versus those that were installed 

outdoors. Bob said he didn't have any data but thought an assumption of 75% versus 25% 

split between machines installed indoors versus outdoors, respectively, was a valid 

assumption. 

________________________________

Thank you very much.

Sriram, S.

EERE-2006-STD-0125 COMMENT 32
##### 



Exhibit 99.4

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 40-F of Extendicare Inc. (the
Company) for the year ended December 31, 2002 (the Report) each of the
undersigned officers of the Company certify solely for purposes of complying
with 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:



|(1) |  | the Report fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and                               
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) |  | the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.

/s/ Mel Rhinelander
Mel Rhinelander
President and Chief Executive Officer
May 16, 2003

/s/ Mark W. Durishan
Mark W. Durishan
Vice President, Finance and Chief Financial Officer
May 16, 2003

A signed original of this written statement required by Section 906 has been
provided to Extendicare Inc. and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE FINANCIAL
STATEMENTS OF VISION HEALTH CARE, INC. AS OF AND FOR THE YEAR ENDED DECEMBER 31,
1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       2,691,316
<SECURITIES>                                 2,500,000
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,214,077
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               5,214,077
<CURRENT-LIABILITIES>                        2,503,603
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         4,224
<OTHER-SE>                                   2,694,426
<TOTAL-LIABILITY-AND-EQUITY>                 5,214,077
<SALES>                                              0
<TOTAL-REVENUES>                                14,514
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 14,514
<INCOME-TAX>                                     2,690
<INCOME-CONTINUING>                             14,514
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,824
<EPS-PRIMARY>                                      .02
<EPS-DILUTED>                                        0


</TABLE>
<PAGE>
                                                                    EXHIBIT 23.3



                         CONSENT OF INDEPENDENT AUDITORS


We hereby consent to the incorporation by reference in the Registration
Statement on Form S-8 (No. 333-62243), Form S-8 (No. 333-70689), Form S-8 (No.
33-00020), Form S-8 (No. 333-94121), Form S-8 (No. 333-38725), Form S-8 (No.
333-02374), Form S-8 (No. 333-107092), and Form S-8 (No. 333-107093) of our
report dated March 11, 2004 relating to the financial statements and financial
statement schedule, appearing on page 54 of Post Properties, Inc.'s Form 10-K
for the year ended December 31, 2003.


PricewaterhouseCoopers LLP
Atlanta, Georgia
March 11, 2004
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 8-K
 CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported)
 March 13, 2008
 CERADYNE, INC.
  Delaware
    
    000-13059
    
    33-0055414(State or other jurisdiction of
    
    (Commission File Number)
    
    (IRS Employer Identification No.)incorporation)
 3169 Red Hill Avenue, Costa Mesa, CA
    
    92626(Address of principal executive offices)
    
    (Zip Code)
   o
 o
 o
 o
   Exhibit Index
on page 4




---



TABLE OF CONTENTS  Item 7.01 Regulation FD DisclosureItem 9.01 Financial Statements and ExhibitsSIGNATURESEXHIBIT INDEXEXHIBIT 99.1    Table of Contents  
 Item 7.01 Regulation FD Disclosure.
   
 Item 9.01 Financial Statements and Exhibits.
 (d)
    
    Exhibits.
 Exhibit Number
    
    Description99.1
    
    
    Press release of Ceradyne, Inc. dated March 13, 2008.
 2




---



##### Table of Contents



SIGNATURES
  CERADYNE, INC.March 14, 2008
    By:
    /s/ Jerrold J. PellizzonJerrold J. PellizzonChief Financial Officer and Secretary 3




---



##### Table of Contents



EXHIBIT INDEX
 Exhibit Number
    
    Description99.1
    
    
    Press release of Ceradyne, Inc. dated March 13, 2008.
 4
<PAGE>
 
                                                                      EXHIBIT 21
 
THE REGISTRY, INC.
 
LIST OF SUBSIDIARIES:
 
<TABLE>
<S>                                             <C>
                                                STATE OF INCORPORATION
                                                       OR ORGANIZATION
1045795 ONTARIO, INC.                           ONTARIO, CANADA
AMERICA'S REGISTRY, INC.                        MASSACHUSETTS
APPLICATION RESOURCES, INC.                     CALIFORNIA
ARI NATIONAL COMPANY                            MASSACHUSETTS
C.M. MANAGEMENT SYSTEMS LTD. INC.               MASSACHUSETTS
COBA CONSULTING LIMITED                         U.K.
COBA GROUP, U.S.A., LTD.                        GEORGIA
CONNEXUS CONSULTING GROUP, INC.                 DELAWARE
ELIGIBILITY MANAGEMENT SYSTEMS, INC.            FLORIDA
INTERNATIONAL SYSTEMS SERVICES (UK)             U.K.
INTERNATIONAL SYSTEMS SERVICES CORPORATION      CONNECTICUT
INTERNATIONAL SYSTEMS SERVICES (UK) LIMITED     U.K.
MCCLAIN GROUP, INC.                             VIRGINIA
THE REGISTRY HOLDING LIMITED                    U.K.
THE REGISTRY, INC. NETWORK CONSULTING PRACTICE  NEW HAMPSHIRE
THE REGISTRY INTERNATIONAL, INC.                DELAWARE
RENAISSANCE SECURITIES CORP.                    MASSACHUSETTS
RENAISSANCE SOLUTIONS, INC.                     DELAWARE
RENAISSANCE SOLUTIONS, LIMITED                  U.K.
SHAMROCK COMPUTER RESOURCES, LTD.               IOWA
STERLING INFORMATION GROUP, INC.                DELAWARE
TECHNOMICS CONSULTANTS INTERNATIONAL, INC.      ILLINOIS
TRI SECURITIES CORP.                            MASSACHUSETTS
</TABLE>
II

104TH CONGRESS

2D SESSION S. 2025

To amend the Communications Act of 1934 to authorize the States to regulate

interference with radio frequencies.

IN THE SENATE OF THE UNITED STATES

AUGUST 2, 1996

Mr. FEINGOLD introduced the following bill; which was read twice and

referred to the Committee on Commerce, Science, and Transportation

A BILL

To amend the Communications Act of 1934 to authorize

the States to regulate interference with radio frequencies.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. AUTHORITY OF STATES TO REGULATE RADIO

4 FREQUENCY INTERFERENCE.

5 Section 302 of the Communications Act of 1934 (47

6 U.S.C. 302) is amended by adding at the end the follow7 ing:

8 ‘‘(e) Where radio frequency interference to home elec9 tronic equipment is caused by a CB radio station through

10 the use of a transmitter or amplifier that is not authorized
2

S 2025 IS

1 for use by a CB radio station pursuant to Commission

2 rules, the State, county, municipal, or other local govern3 ment shall not be preempted from exercising its police

4 powers to resolve the interference by prohibiting the use

5 of such unauthorized equipment or by imposing fines or

6 other monetary sanctions. For purpose of this subsection,

7 home electronic equipment includes, but is not limited to,

8 television receivers, radio receivers, stereo components or

9 systems, video cassette recorders, audio recorders, loud

10 speakers, telephone equipment and other electronic devices

11 normally used in the home. Any action taken by the State,

12 county, municipal, or local government shall not preclude

13 concurrent action by the Commission. Nothing in this sub14 section shall be construed to diminish the Commission’s

15 exclusive jurisdiction over radio frequency interference in

16 any matter outside the scope of this subsection.’’.

Æ
**Exhibit 31.2**
**CHIEF FINANCIAL OFFICER CERTIFICATION**
I, Michael G. McGrath, Chief Financial Officer of Accenture Ltd, the general partner of AccentureSCA (the “Registrant”), certify that:
1. I have reviewed the Registrant’s Quarterly Report on Form 10-Q for the period ended May 31,2005 as filed with the Securities and Exchange Commission on the date hereof; 2. Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading with respect to theperiod covered by this quarterly report; 3. Based on my knowledge, the financial statements, and other financial information included inthis quarterly report, fairly present in all material respects the financial condition,results of operations and cash flows of the Registrant as of, and for, the period presented inthis quarterly report; 4. The Registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the Registrant and have:
 a) Designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that material informationrelating to the Registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;  b) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures andpresented in this quarterly report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this quarterlyreport based on such evaluation; and  c) Disclosed in this quarterly report any change in the Registrant’s internal control overfinancial reporting that occurred during the Registrant’s most recent fiscal quarter thathas materially affected, or is reasonably likely to materially affect, the Registrant’sinternal control over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the Registrant’s auditors and theaudit committee of Registrant’s board of directors (or persons performing the equivalentfunctions):
 a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe Registrant’s ability to record, process, summarize and report financial information;and  b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the Registrant’s internal controls over financial reporting.
Dated: July 11, 2005              /s/  Michael G. McGrath   Michael G. McGrath   Chief Financial Officer of Accenture Ltd,General Partner of Accenture SCA(principal financial officer)